{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-223802","form_type":"8-K","ticker":null,"cik":"0001850079","company_name":"Telesis Bio Inc.","filed_at":"2023-08-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.758287+00:00","generated_at":"2026-06-11T02:32:25.363577+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Telesis Bio appoints William Kullback as CFO effective August 28, 2023","bullets":["Kullback's base salary set at $430,000 with target bonus of 50% of salary and $100,000 signing bonus.","Company will recommend a grant of an option to purchase 300,000 shares of common stock.","Previously CFO at BioLegend, where he led its $5.25B sale to Revvity (PerkinElmer).","Kullback also served as CFO at Lombard Medical (Nasdaq: EVAR) from 2014 to 2017."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-223802","json":"https://secwatch.observer/filing/0001193125-23-223802.json","markdown":"https://secwatch.observer/filing/0001193125-23-223802.md","text":"https://secwatch.observer/filing/0001193125-23-223802.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850079/000119312523223802/0001193125-23-223802-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850079/000119312523223802/d333931d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T02:32:25.363577+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a6358024b5","claim":"William Kullback was appointed as Chief Financial Officer at Telesis Bio Inc..","evidence_excerpt":"On August 28, 2023, the Company appointed William Kullback, age 63, as Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1850079/000119312523223802/0001193125-23-223802-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}